Subscribe To

Price Alert Latest News Economic Calendar News

TFX / Should You Buy Teleflex Stock At $225?

Teleflex stock (NYSE: TFX), best known for its single-use medical devices for common diagnostic and therapeutic procedures, has seen a 31% fall this year, underperforming the broader S&P500 index, down 16%. Read More

Demo Live Account See Partner Details

Content Topics

Should

Teleflex

Stock

225 TFX

Posted: Nov 28 2022, 08:45

Author Name: Forbes

TFX News

By Zacks Investment Research
November 3, 2023

Teleflex (TFX) Q3 Earnings Top Estimates, 2023 Outlook Up

Teleflex's (TFX) year-over-year revenue growth was driven by all global product categories in Q3.

By Reuters
November 2, 2023

Teleflex beats profit estimates on strong demand for medical devices

Teleflex beat third quarter profit estimates on Thursday as volumes of non-urgent surgical procedures picked up in hospitals post pandemic, lifting de

By GlobeNewsWire
October 31, 2023

Teleflex to Present at the Jefferies London Healthcare Conference

WAYNE, Pa., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the

By GlobeNewsWire
October 19, 2023

Teleflex Announces Third Quarter 2023 Earnings Conference Call Information

WAYNE, Pa., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its third quarter financial resu

By Zacks Investment Research
October 13, 2023

Teleflex (TFX) Advances Urology Portfolio With New Buyout

Teleflex's (TFX) recent buyout is in line with its strategy of acquiring assets that accelerate the rate of expansion.

By Seeking Alpha
October 12, 2023

Teleflex Shares Hit Hard As Growth Concerns Stack Up

Teleflex shares have lagged a weak medical device market, with growing concerns about the company's internal growth capabilities and its need to turn

By Zacks Investment Research
September 18, 2023

Teleflex (TFX) Rides on Urolift Prospects Amid Cost Pressures

With respect to Teleflex's (TFX) market development objectives for UroLift, the company witnesses growth for UroLift in the hospital setting.

By Zacks Investment Research
September 5, 2023

Here's Why You Should Retain Teleflex (TFX) Stock for Now

A diversified product portfolio and a broad geographic footprint bode well for Teleflex (TFX).

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.